First Page | Document Content | |
---|---|---|
Date: 2011-11-03 09:32:07Nitriles Organofluorides Benzamides Lactams MDV3100 Thioureas Prostate cancer Docetaxel Prostate Chemistry Organic chemistry Anatomy | Medivation Contacts: Patrick Machado Chief Business & Financial Officer[removed]Astellas Contacts:Add to Reading ListSource URL: www.astellas.comDownload Document from Source WebsiteFile Size: 129,32 KBShare Document on Facebook |
Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company RelocationDocID: 19pfm - View Document | |
5.5 ENZALUTAMIDE, capsule, 40 mg, Xtandi®, Astellas Pharma Australia Pty Ltd, Purpose of Application Authority required (Streamlined) listing for enzalutamide for treatment of metastatic prostate cancer after treatmentDocID: 17GTi - View Document | |
PDF DocumentDocID: 16Qjm - View Document | |
Microsoft PowerPoint - Figure MQ[removed]DocID: ZzdJ - View Document | |
Queensland Prostate Cancer News This magazine is a publication of the Queensland Chapter, Prostate Cancer Foundation of Australia. Letter from the EditorDocID: YHLd - View Document |